Glaucoma Surgery Devices

Global Glaucoma Surgery Devices Market to Reach US$8.3 Billion by 2030

The global market for Glaucoma Surgery Devices estimated at US$2.6 Billion in the year 2024, is expected to reach US$8.3 Billion by 2030, growing at a CAGR of 21.0% over the analysis period 2024-2030. Traditional, one of the segments analyzed in the report, is expected to record a 20.8% CAGR and reach US$3.1 Billion by the end of the analysis period. Growth in the Minimal Invasive segment is estimated at 23.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$669.6 Million While China is Forecast to Grow at 26.6% CAGR

The Glaucoma Surgery Devices market in the U.S. is estimated at US$669.6 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2030 trailing a CAGR of 26.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.8% and 18.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 17.4% CAGR.

Global Glaucoma Surgery Devices Market - Key Trends and Drivers Summarized

How Are Glaucoma Surgery Devices Evolving to Meet Rising Demand?

Glaucoma surgery devices play a crucial role in the treatment of glaucoma, a leading cause of blindness worldwide. These devices are designed to reduce intraocular pressure (IOP) in patients where medications or less invasive treatments have failed. With advancements in ophthalmology, glaucoma surgery has evolved from traditional, invasive procedures to minimally invasive glaucoma surgeries (MIGS), which reduce recovery times and improve patient outcomes. Devices such as shunts, stents, and laser-based systems are used to drain fluid and lower IOP, preventing further damage to the optic nerve. As the aging population grows and awareness of glaucoma increases, the demand for effective surgical treatments is on the rise.

What Are the Major Segments and Applications of Glaucoma Surgery Devices?

The glaucoma surgery devices market is segmented by product type, including drainage implants, stents, and laser devices. Drainage implants, such as aqueous shunts, are used in patients with advanced glaucoma to create new drainage pathways for fluid. MIGS devices, including tiny stents that are implanted in the eye, are gaining popularity due to their less invasive nature and lower risk profiles. Laser systems, which include selective laser trabeculoplasty (SLT) and argon laser trabeculoplasty (ALT), are used to improve fluid outflow. The market is also segmented by end-users, such as hospitals, ambulatory surgical centers, and ophthalmic clinics. North America and Europe dominate the market due to advanced healthcare infrastructure and high glaucoma prevalence, while Asia-Pacific is witnessing rapid growth as healthcare access improves.

How Are Technological Innovations Impacting Glaucoma Surgery Devices?

Technological advancements are revolutionizing glaucoma surgery devices, particularly in the development of minimally invasive solutions. MIGS devices are at the forefront of innovation, offering safer and more effective options for glaucoma patients who are not candidates for traditional surgery. These devices reduce trauma to the eye and speed up recovery times, making them increasingly popular among ophthalmologists and patients alike. Advances in laser technologies are also enhancing the precision and effectiveness of glaucoma surgeries, while smart implants that monitor intraocular pressure in real-time are poised to transform post-surgical care. Furthermore, artificial intelligence and robotics are beginning to enter the field, offering new possibilities for precision surgeries and outcome prediction.

What Factors Are Driving the Growth in the Glaucoma Surgery Devices Market?

The growth in the glaucoma surgery devices market is driven by several factors, including the rising prevalence of glaucoma, particularly among the aging population. Technological advancements in minimally invasive surgical techniques are making glaucoma surgery safer and more accessible, driving increased adoption. Growing awareness about early diagnosis and treatment of glaucoma is expanding the market for surgical devices as patients seek more effective solutions. Additionally, increased healthcare expenditure and favorable reimbursement policies in developed regions are supporting market growth. In emerging markets, improved healthcare infrastructure and access to advanced ophthalmic treatments are further fueling the demand for glaucoma surgery devices.

SCOPE OF STUDY:

The report analyzes the Glaucoma Surgery Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Surgery Method (Traditional, Minimal Invasive, Laser); End-Use (Hospitals, Ophthalmic Clinics, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Abbott Medical Optics
• Alcon, Inc.
• Allergan Plc.
• ASICO
• Carl Zeiss Meditec AG
• Glaukos Corporation
• Iridex Corporation
• Johnson & Johnson
• Katalyst Surgical
• Lumenis Ltd.
• Nidek Co., Ltd.
• Santen Pharmaceutical Co., Ltd.
• Sight Sciences, Inc.
• Ziemer Ophthalmic Systems AG

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.